5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.52▲ | 3.54▲ | 3.57▲ | 3.76▼ | 3.37▲ |
MA10 | 3.55▲ | 3.61▲ | 3.66▲ | 3.50▲ | 3.39▲ |
MA20 | 3.69▲ | 3.78▼ | 3.74▼ | 3.40▲ | 3.25▲ |
MA50 | 3.79▼ | 3.54▲ | 3.43▲ | 3.38▲ | 3.31▲ |
MA100 | 3.56▲ | 3.39▲ | 3.37▲ | 3.24▲ | 3.87▼ |
MA200 | 3.39▲ | 3.38▲ | 3.37▲ | 3.29▲ | 4.43▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.011▼ | -0.047▼ | -0.047▼ | 0.048▲ | 0.038▲ |
RSI | 52.348▲ | 53.189▲ | 55.379▲ | 57.489▲ | 57.240▲ |
STOCH | 16.667▼ | 20.091 | 16.228▼ | 73.448 | 55.658 |
WILL %R | -6.452▲ | -48.214 | -50.847 | -32.609 | -25.172 |
CCI | 92.848 | 8.372 | -12.749 | 78.545 | 125.757▲ |
Tuesday, September 23, 2025 05:14 AM
Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced ...
|
Monday, September 22, 2025 05:35 AM
SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its ...
|
Thursday, September 04, 2025 06:01 PM
BOSTON and ROLLE, Switzerland, Sept. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, has announced a ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/09/25 | 3.72 | 3.72 | 3.585 | 3.72 | 951 |
25/09/25 | 3.72 | 3.74 | 3.3691 | 3.43 | 65,735 |
24/09/25 | 3.95 | 3.9825 | 3.68 | 3.78 | 34,052 |
23/09/25 | 3.87 | 4.02 | 3.82 | 3.96 | 118,414 |
22/09/25 | 3.24 | 3.93 | 3.21 | 3.93 | 181,981 |
19/09/25 | 3.20 | 3.40 | 3.15 | 3.32 | 43,784 |
18/09/25 | 3.28 | 3.359 | 3.15 | 3.19 | 39,850 |
17/09/25 | 3.23 | 3.35 | 3.22 | 3.23 | 21,866 |
16/09/25 | 3.16 | 3.2508 | 3.15 | 3.23 | 20,533 |
15/09/25 | 3.12 | 3.2222 | 3.12 | 3.17 | 14,480 |
|
|
||||
|
|
||||
|
|